Systematic review with meta-analysis: highly selective 5-HT4 agonists (prucalopride, velusetrag or naronapride) in chronic constipation (Q35059682)

6 August 2017

0 references

Systematic review with meta-analysis: highly selective 5-HT4 agonists (prucalopride, velusetrag or naronapride) in chronic constipation (English)

1 reference

6 August 2017

1 reference

1 reference

A Shin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24308797 AND SRC:MED&resulttype=core&format=json

10 June 2020

M Camilleri

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24308797 AND SRC:MED&resulttype=core&format=json

10 June 2020

G Kolar

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24308797 AND SRC:MED&resulttype=core&format=json

10 June 2020

P Erwin

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24308797 AND SRC:MED&resulttype=core&format=json

10 June 2020

language of work or name

English

0 references

publication date

5 December 2013

1 reference

Alimentary Pharmacology & Therapeutics

6 August 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24308797 AND SRC:MED&resulttype=core&format=json

10 June 2020

volume

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24308797 AND SRC:MED&resulttype=core&format=json

10 June 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24308797 AND SRC:MED&resulttype=core&format=json

10 June 2020

page(s)

239-253

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24308797 AND SRC:MED&resulttype=core&format=json

Prevalence of, and risk factors for, chronic idiopathic constipation in the community: systematic review and meta-analysis

10 June 2020

cites work

1 reference

Chronic constipation: a survey of the patient perspective

21 January 2018

1 reference

5-HT4 receptor agonists: similar but not the same

21 January 2018

1 reference

An improved in vitro bioassay for the study of 5-HT(4) receptors in the human isolated large intestinal circular muscle

21 January 2018

1 reference

Block of the Rapid Component of the Delayed Rectifier Potassium Current by the Prokinetic Agent Cisapride Underlies Drug-Related Lengthening of the QT Interval

21 January 2018

1 reference

Prucalopride for constipation

21 January 2018

1 reference

The in vitro pharmacological profile of TD-5108, a selective 5-HT(4) receptor agonist with high intrinsic activity

21 January 2018

1 reference

The in vivo gastrointestinal activity of TD-5108, a selective 5-HT(4) receptor agonist with high intrinsic activity

21 January 2018

1 reference

Systematic review: cardiovascular safety profile of 5-HT(4) agonists developed for gastrointestinal disorders

21 January 2018

1 reference

Tegaserod-induced myocardial infarction: case report and hypothesis

21 January 2018

1 reference

Effect of laxatives and pharmacological therapies in chronic idiopathic constipation: systematic review and meta-analysis

21 January 2018

1 reference

Prucalopride: evaluation of the pharmacokinetics, pharmacodynamics, efficacy and safety in the treatment of chronic constipation

21 January 2018

1 reference

Development and validation of the Patient Assessment of Constipation Quality of Life questionnaire

21 January 2018

1 reference

Psychometric validation of a constipation symptom assessment questionnaire

21 January 2018

1 reference

Quantifying heterogeneity in a meta-analysis

21 January 2018

1 reference

Prucalopride is effective in patients with severe chronic constipation in whom laxatives fail to provide adequate relief. Results of a double-blind, placebo-controlled clinical trial

21 January 2018

1 reference

Prucalopride in the treatment of chronic constipation in patients from the Asia-Pacific region: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

A placebo-controlled trial of prucalopride for severe chronic constipation

21 January 2018

1 reference

Prucalopride, a systemic enterokinetic, for the treatment of constipation

21 January 2018

1 reference

A double-blind, placebo-controlled study of prucalopride in elderly patients with chronic constipation

21 January 2018

1 reference

Prucalopride accelerates gastrointestinal and colonic transit in patients with constipation without a rectal evacuation disorder

21 January 2018

1 reference

Clinical trial: the efficacy and tolerability of velusetrag, a selective 5-HT4 agonist with high intrinsic activity, in chronic idiopathic constipation - a 4-week, randomized, double-blind, placebo-controlled, dose-response study

21 January 2018

1 reference

Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives

21 January 2018

1 reference

Clinical trial: the efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation--a 12-week, randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

Safety assessment of prucalopride in elderly patients with constipation: a double-blind, placebo-controlled study

21 January 2018

1 reference

Randomised clinical trial: macrogol/PEG 3350 electrolytes versus prucalopride in the treatment of chronic constipation -- a comparison in a controlled environment

21 January 2018

1 reference

Effects of prucalopride on colonic transit, anorectal function and bowel habits in patients with chronic constipation

21 January 2018

1 reference

Measurement of health status. Ascertaining the minimal clinically important difference

21 January 2018

1 reference

Clinical trial: the efficacy of open-label prucalopride treatment in patients with chronic constipation - follow-up of patients from the pivotal studies

21 January 2018

1 reference

Inclusion criteria for pharmacodynamic and clinical trials in chronic idiopathic constipation: pitfalls in using Rome III for functional constipation

21 January 2018

1 reference

Biofeedback is superior to laxatives for normal transit constipation due to pelvic floor dyssynergia.

21 January 2018

1 reference

Why Most Discovered True Associations Are Inflated

21 January 2018

1 reference